PACT Recognizes Technology, Healthcare and Life Sciences Innovation and Leaders in the Philadelphia Region at the 2021 Enterprise Awards

Philadelphia, PA., June 30, 2021 PACT, the Philadelphia Alliance for Capital and Technologies, culminated two days celebrating the Philadelphia region’s technology, healthcare and life sciences innovators and leaders tonight at the 2021 PACT Enterprise Awards. Following the region’s first, large-scale gathering post-pandemic, the virtual event recognized 27 outstanding individuals and organizations through nine competitive categories. Josh Kopelman was recognized during Tuesday’s in-person event as the Legend Award Honoree, an award presented annually to an individual who has actively supported technology and innovation in the region through leadership and exemplary work.

“As the leading association for technology and life sciences in the Philadelphia region, PACT is incredibly proud to welcome the community back to celebrate the local investors, entrepreneurs and businesses who are transforming life sciences, healthcare and technology and their related fields worldwide,” said Dianne Strunk, Vice President, PACT. “The Enterprise Awards have a long history of recognizing those making a tremendous impact, and it’s my honor to congratulate each of them on their success.”

Introducing the 2021 PACT Enterprise Awards winners:

  • Healthcare Innovator: NeuroFlow – Philadelphia, PA
  • Life Sciences & Healthcare CEO: Maria Maccecchini, Annovis Bio – Berwyn, PA
  • Life Sciences & Healthcare Emerging: Incyte – Wilmington, DE
  • Life Sciences & Healthcare Startup: Envara Health, Inc. – Malvern, PA
  • Technology Company: Suvoda – Conshohocken, PA
  • Technology CEO: Larry Berran, iPipeline – Exton, PA
  • Technology Emerging: Greenphire – King of Prussia, PA
  • Technology Startup: CrossBeam – Philadelphia, PA
  • Investment Deal: Vertex – King of Prussia, PA

In addition to the competitive award categories, PACT recognized Josh Kopelman, Founding Partner of First Round Capital as the Legend Award Honoree, during the in-person celebration event the prior evening.

Josh has consistently ranked in the top 20 of Forbes annual “Midas List” of the top 100 tech investors. Before becoming a venture capitalist, Josh founded three companies: In 1992 Josh co-founded Infonautics Corporation – taking it public in 1996. Josh co-founded in 1999 and led the company through its acquisition by eBay. And in 2003 Josh helped to found TurnTide, an anti-spam company that was acquired by Symantec. Josh is an inventor on over a dozen U.S. Patents for his work in Internet technology. On a local level, Josh also serves as Chairman of the Board for The Philadelphia Inquirer, LLC and is a member of the board of directors of the Ed Snider Youth Hockey Foundation.

The full 2021 Enterprise Awards Broadcast can be found on our YouTube Channel by clicking HERE


About Philadelphia Alliance for Capital and Technologies (PACT) 

PACT’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region.




Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Integrated with the company’s industry-leading site payment technology, the new solution delivers efficiency and accuracy to support a streamlined and optimized study start-up

KING OF PRUSSIA, Pa. – June 2, 2020 – Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up. The new budget development solution streamlines trial initiation for sponsors and CROs and eliminates guesswork during the budgeting process to deliver a smarter, more efficient workflow.

EnvisiX seamlessly integrates with eClinicalGPS, Greenphire’s industry-leading site payment solution, enabling unprecedented simplicity and efficiency throughout a trial from budget creation and negotiation to management, execution, and tracking of global investigator grants.

Read more.

Greenphire Launches Extension of its ConneX Solution, ConneX Patient Direct, as Trial Sites Seek Support in Response to COVID-19

New service allows clinical trial sites around the world to safely transport medications, equipment, and healthcare professionals to patients’ homes, ensuring needed patient support and enabling clinical trials to continue

KING OF PRUSSIA, Pa.April 8, 2020 /PRNewswire/ — Greenphire, the global leader in financial software for clinical trials, today announced the launch of its ConneX Patient Direct service to enable global clinical trial sites to continue their critical work and patient support in an effort to offset the impact of COVID-19. The new service, which is an extension of Greenphire’s ConneX concierge travel solution for clinical trials, provides “clean transport” for medications, equipment and healthcare professionals to visit patients in their homes, enabling patients to receive much-needed medications and monitoring, and sites and sponsors to continue their trials without disruption.

New FDA and EMA Guidelines for the conduct of clinical trials during COVID-19 pave the way for sponsors to evaluate whether alternative methods for safety assessments could be implemented when necessary and feasible, and would be sufficient to assure the safety of trial participants.

Read more.